C. Potolidis

Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure.

J. Wojta, L. Koller, R. Berger, 2017, JACC. Heart failure.

Clusterin/apolipoprotein J is independently associated with survival in patients with chronic heart failure.

J. Wojta, L. Koller, I. Lang, 2017, Journal of clinical lipidology.

Frailty and outcomes in heart failure patients from high-, middle-, and low-income countries

G. C. Sharma, S. Yusuf, P. López-Jaramillo, 2023, European heart journal.